Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Therapeutic Effect and Safety of Combined Hydroxyurea With Recombinant Human Erythropoietin.

NCT01624038 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT01624038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01624038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Therapeutic Effect and Safety of Combined Hydroxyurea With Recombinant Human Erythropoietin.
Lead sponsor
Ain Shams University
Phase
Phase 2/3
Overall status
Unknown status
Start date
June 30, 2012
Completion date
December 31, 2012
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thalassemia intermedia